Skip to main content
Log in

Synergismus von Netilmicin und anderen Aminoglykosiden mit Cefotaxim gegen nosokomiale, nicht fermentierende Erreger

The synergism of netilmicin and other aminoglycosides with cefotaxime against nosocomial, non-fermenting causative agents

  • Mikrobiologie
  • Published:
Infection Aims and scope Submit manuscript

Zusammenfassung

Mit der Checkerboard-Agar-Dilutionsmethode wurde die Kombinationswirkung von Cefotaxim mit Netilmicin und anderen Aminoglykosiden gegen 57 nicht fermentierende gramnegative Bakterien (Pseudomonas aeruginosa, Pseudomonas cepacia, Pseudomonas maltophilia, Pseudomonas fluorescensputida, Acinetobacter anitratus, Acinetobacter lwoffi) überprüft, die von Patienten mit im Krankenhaus erworbenen Infektionen isoliert worden waren. Durchschnittlich 39% der Nonfermenter wurden durch Cefotaxim-Aminoglykosid-Kombinationen additiv, 14% synergistisch gehemmt. Die additive und synergistische Wirkung war am besten beiP. aeruginosa, P. maltophilia undP. fluorescens-putida Stämmen, am niedrigsten gegenAcinetobacter Spezies; gegenP. cepacia Stämme trat kein Synergismus auf. Die additiven und/oder synergistischen Kombinationen senkten die minimalen Hemmkonzentrationen von Cefotaxim, Netilmicin und anderen Aminoglykosiden bei fast allen Stämmen auf therapeutisch erreichbare Serumkonzentrationen.

Summary

Using the checkerboard agar dilution method, the combined effect of cefotaxime with netilmicin and other aminoglycosides on 57 non-fermenting, gram-negative bacteria (Pseudomonas aeruginosa, Pseudomonas cepacia, Pseudomonas maltophilia, Pseudomonas fluorescensputida, Acinetobacter anitratus, Acinetobacter lwoffi) was tested. These bacteria had been isolated from patients with nosocomial infections. An average of 39% of the non-fermenting bacteria were inhibited by the additive effect of cefotaxime-aminoglycoside combinations. 14% on the average by the synergistic effect. The additive and synergistic effect was greatest againstP. aeruginosa, P. maltophilia andP. fluorescens-putida strains and weakest againstAcinetobacter species. No synergism was found withP. cepacia strains. The additive and/or synergistic combinations reduced the minimal inhibitory concentrations of cefotaxime, netilmicin and other aminoglycosides to therapeutically attainable serum concentrations for nearly all strains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Ramphal, R., Kluge, R. M. Acinetobacter calcoaceticus varietyanitratus: An increasing nosocomial problem. Am. J. Med. Sci. 277 (1979) 57–66.

    Google Scholar 

  2. Center for Disease Control Morbidity and Mortality Weekly Report 28 (1979) 169–171.

    Google Scholar 

  3. Fluornoy, D. J. Netilmicin synergy with carbenicillin or cefamandole againstSerratia. J. Antibiot. 31 (1977) 131–134.

    Google Scholar 

  4. Yoshikawa, Th. T., Shibata, Sh. A., Chow, A. W., Guze, L. B. Outbreak of multiply drug resistantProteus mirabilis originating in a surgical intensive care unit: In vitro susceptibility pattern. Antimicrob. Agents Chemother. 13 (1978) 177–179.

    Google Scholar 

  5. Habwe, V., Smith, S. Comparative in vitro studies with netilmicin, amikacin, gentamycin, sisomycin and tobramycin. J. Antimicrob. Chemother. 5 (1979) 73–79.

    Google Scholar 

  6. Snydman, D. R., Tally, F. P., Landesman, Sh. H., Barza, M., Gorbach, Sh. L. Netilmicin in gram-negative bacterial infections. Antimicrob. Agents Chemother. 15 (1979) 50–54.

    Google Scholar 

  7. Bowan, R. L., Silverblatt, F. J., Kaloyanides, G. J. Comparison of the nephrotoxicity of netilmicin and gentamycin in rats. Antimicrob. Agents Chemother. 12 (1977) 474–478.

    Google Scholar 

  8. Neu, H. C., Aswapokee, N., Aswapokee, P., Fu, K. P. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 15 (1979) 273–281.

    Google Scholar 

  9. Daschner, F. D., Steffens, A., Langmaack, H. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides againstPseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae andProteus strains. Chemotherapy 25 (1979) 282–285.

    Google Scholar 

  10. Korzeniowski, O. M., Wennersten, Ch., Moellering, R. C., Sande, M. A. Penicillin-netilmicin synergism againstStreptococcus faecalis. Antimicrob. Agents Chemother. 13 (1978) 430–434.

    Google Scholar 

  11. Sanders, Ch. C. Synergy of penicillin-netilmicin combinations against enterococci including strains highly resistant to streptomycin or kanamycin. Antimicrob. Agents Chemother. 12 (1977) 195–200.

    Google Scholar 

  12. Watanakunakorn, Ch., Glotzbecker, Ch. In vitro activity of sisomycin and netilmicin alone and in combination with nafcillin, oxacillin and methicillin against enterococci. Chemotherapy 24 (1978) 236–239.

    Google Scholar 

  13. Watanakunakorn, Ch., Glotzbecker, Ch. Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomycin and netilmicin. Antimicrob. Agents Chemother. 12 (1977) 346–348.

    Google Scholar 

  14. Fu, K. P., Neu, H. C. The comparative synergistic activity of amikacin, gentamycin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin againstSerratia marcescens. J. Antibiot. 31 (1977) 135–140.

    Google Scholar 

  15. Pogwizd, St. M., Lerner, S. A. In vitro activity of gentamycin, amikacin and netilmicin alone and in combination with carbenicillin againstSerratia marcescens. Antimicrob. Agents Chemother. 10 (1976) 878–884.

    Google Scholar 

  16. Marks, M. I., Hammerberg, S., Greenstone, G., Silver, B. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamycin-resistantPseudomonas aeruginosa. Antimicrob. Agents Chemother. 10 (1976) 399–401.

    Google Scholar 

  17. Valenti, A. J., Marier, R. L., Downs, J. T., Andriole, V. T. Synergy studies. Carbenicillin-netilmicin synergy in experimental infection withPseudomonas. Curr. Chemother. 1 (1978) 416–418.

    Google Scholar 

  18. Pickering, L. K., Gearhart, P. Effect of time and concentration upon interaction between gentamycin, tobramycin, netilmicin or amikacin and carbenicillin or ticarcillin. Antimicrob. Agents Chemother. 15 (1979) 592–596.

    Google Scholar 

  19. Fu, K. P., Neu, H. C. In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. Antimicrob. Agents Chemother. 10 (1976) 511–518.

    Google Scholar 

  20. Lüthy, R., Münch, R., Blaser, J., Bhend, H., Siegenthaler, W. Human pharmacology of cefotaxime (HR 756), a new cephalosporin. Antimicrob. Agents Chemother. 16 (1979) 127–133.

    Google Scholar 

  21. Klastersky, J., Neunier-Carpentier, F., Coppens-Kahan, L., Daneau, D., Prevost, J. M. Clinical and bacteriological evaluation of netilmicin in gram-negative infections. Antimicrob. Agents Chemother. 12 (1977) 500–509.

    Google Scholar 

  22. Klastersky, J., Cappel, R., Daneau, D. Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob. Agents Chemother. 2 (1972) 470–475.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daschner, F.D., Steffens, A., Just, M. et al. Synergismus von Netilmicin und anderen Aminoglykosiden mit Cefotaxim gegen nosokomiale, nicht fermentierende Erreger. Infection 8 (Suppl 4), S433–S436 (1980). https://doi.org/10.1007/BF01639413

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01639413

Navigation